FDA Panel Member Tells Healthline Why He Resigned Over Alzheimer's Drug Approval

Dr. Aaron S. Kesselheim resigned in mid-June from an advisory panel of the Food and Drug Administration after the approval of a new Alzheimer's drug.

	FDA Panel Member Tells Healthline Why He Resigned Over Alzheimer's Drug Approval Dr. Aaron S. Kesselheim resigned in mid-June from an advisory panel of the Food and Drug Administration after the approval of a new Alzheimer's drug. Read on Why Is the FDA Warning About Nitrite Poppers? READ ON The Price We Paid: How Reopenings Last Year Affected COVID-19 Hospitalizations, Deaths READ ON People on High-Deductible Plan More Likely to Avoid ER, Even If They Have Chest Pain READ ON Got the Hiccups? This L-Shaped Straw Device May Be the Cure You Need READ ON More Top Reads Follow Us View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy Policy|Unsubscribe © 2021 Healthline Media 660 3rd Street, San Francisco, CA 94107